Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Amortizatization of Intangibles: 2022-2025

Historic Amortizatization of Intangibles for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to $705,000.

  • Praxis Precision Medicines' Amortizatization of Intangibles fell 64.84% to $705,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 12.32%. This contributed to the annual value of $5.0 million for FY2024, which is 498.57% up from last year.
  • Latest data reveals that Praxis Precision Medicines reported Amortizatization of Intangibles of $705,000 as of Q3 2025, which was down 28.57% from $987,000 recorded in Q2 2025.
  • Over the past 5 years, Praxis Precision Medicines' Amortizatization of Intangibles peaked at $2.0 million during Q3 2024, and registered a low of -$375,000 during Q1 2022.
  • For the 3-year period, Praxis Precision Medicines' Amortizatization of Intangibles averaged around $797,091, with its median value being $705,000 (2025).
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first skyrocketed by 845.75% in 2024, then plummeted by 64.84% in 2025.
  • Over the past 4 years, Praxis Precision Medicines' Amortizatization of Intangibles (Quarterly) stood at -$196,000 in 2022, then soared by 211.22% to $218,000 in 2023, then spiked by 537.61% to $1.4 million in 2024, then crashed by 64.84% to $705,000 in 2025.
  • Its last three reported values are $705,000 in Q3 2025, $987,000 for Q2 2025, and $1.2 million during Q1 2025.